FTSE 100 news / Companies and sectors / GSK / 18 October 2026
GSK (GSK): news on Sunday 18 October 2026
+0.7 neutral
Coverage was thin, limited to a profile of chief executive Luke Miels and a routine note on the share price ahead of the next Xetra session. Neither story contains news of substance, so the tone is broadly neutral.
What drove it
- CEO profile
- share price update
The 2 stories
- +0.8 Luke Miels: Flinders University Biologist, Global Pharma Leader, and Chief Executive Officer of GSK
Profile of GSK's chief executive; factual, mildly positive. - +0.3 GSK stock heads into the next Xetra session at EUR 22.03 - ad-hoc-news.de
Routine share price note with no clear direction.
GSK: every day · Pharma and healthcare on 18 October 2026 · FTSE 100 overview for the day